首页> 外文期刊>The international journal of artificial organs >Tissue engineering of bladder using vascular endothelial growth factor gene-modified endothelial progenitor cells.
【24h】

Tissue engineering of bladder using vascular endothelial growth factor gene-modified endothelial progenitor cells.

机译:使用血管内皮生长因子基因修饰的内皮祖细胞对膀胱进行组织工程设计。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: This study assessed the use of vascular endothelial growth factor (VEGF) gene-modified endothelial progenitor cells (EPCs) seeded onto bladder acellular matrix grafts (BAMGs), to enhance the blood supply in tissue-engineered bladders in a porcine model. METHODS: Autologous porcine peripheral EPCs were isolated, cultured, expanded, characterized, and modified with the VEGF gene using an adenovirus vector. The expression of VEGF was examined using reverse transcriptase polymerase chain reaction (RT-PCR) and an enzyme-linked immunosorbent assay (ELISA). VEGF gene modified EPCs were seeded onto BAMG and cultured for 3 days before implantation into pigs for bladder tissue engineering. A partial bladder cystectomy was performed in 12 pigs. The experimental group (6 pigs) received VEGF gene-modified EPC-seeded BAMG. The control group (6 pigs) received BAMG without seeded EPCs. The resulting tissue-engineered bladders were subject to a general and histological analysis. Microvessel density (MVD) was assessed using immunohistochemistry. RESULTS: The ex vivo transfection efficiency of EPCs was greater than 60%-70% when concentrated adenovirus was used. The genetically modified cells expressed both VEGF and Green Fluorescent Protein (GFP). Scanning electron microscopy (SEM) and Masson's trichrome staining of cross sections of the cultured cells seeded to BAMG showed cell attachment and proliferation on the surface of the BAMG. Histological examination revealed bladder regeneration in a time-dependent fashion. Significant increases in MVD were observed in the experimental group, in comparison with the control group. CONCLUSIONS: VEGF-modified EPCs significantly enhanced neovascularization, compared with BAMG alone. These results indicate that EPCs, combined with VEGF gene therapy, may be a suitable approach for increasing blood supply in the tissue engineering of bladders. Thus, a useful strategy to achieve a tissue-engineered bladder is indicated.
机译:目的:本研究评估了在猪模型中使用血管内皮生长因子(VEGF)基因修饰的内皮祖细胞(EPC)植入膀胱无细胞基质移植物(BAMG)的方法,以增强组织工程膀胱的血液供应。方法:使用腺病毒载体分离,培养,扩增,表征和修饰自体猪外周血EPC。使用逆转录聚合酶链反应(RT-PCR)和酶联免疫吸附测定(ELISA)检测VEGF的表达。将经VEGF基因修饰的EPC接种到BAMG上并培养3天,然后植入猪中进行膀胱组织工程。在12头猪中进行了部分膀胱膀胱切除术。实验组(6头猪)接受了VEGF基因修饰的EPC接种的BAMG。对照组(6头猪)接受了不含种子EPC的BAMG。对得到的组织工程性膀胱进行一般和组织学分析。使用免疫组织化学评估微血管密度(MVD)。结果:使用浓缩腺病毒时,EPC的体外转染效率大于60%-70%。转基因的细胞表达VEGF和绿色荧光蛋白(GFP)。扫描电镜(SEM)和马森氏三色染色的接种到BAMG的培养细胞的横截面显示在BAMG表面的细胞附着和增殖。组织学检查显示膀胱再生呈时间依赖性。与对照组相比,实验组的MVD明显增加。结论:与单独的BAMG相比,VEGF修饰的EPC显着增强了新血管形成。这些结果表明,EPC与VEGF基因疗法相结合,可能是增加膀胱组织工程中血液供应的合适方法。因此,指出了实现组织工程膀胱的有用策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号